CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
Preclinical data show that therapeutic treatment with Auxora in a rat model of AKI improves kidney function as measured by glomerular filtration rate LA JOLLA, Calif., Feb. 28, 2024 /PRNewswire/ — CalciMedica Inc. (CalciMedica or the Company) (Nasdaq: CALC), a clinical-stage biopharmaceutical
Europe Electric Vehicle Insulation Market Analysis and Forecasts, 2023-2032 – Increasing Government Focus on Strict Regulatory Standards and On-going Trend of Light-weighting to Bolster Growth
DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Europe Electric Vehicle Insulation Market: Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The Europe electric vehicle insulation market (excluding U.K.) is projected to reach $3,336.2
DOVE, TOGETHER WITH ITS COMMUNITY, UNITE VOICES TO PROTECT GIRLS’ SELF-ESTEEM FROM ANTI-AGEING SKINCARE PRESSURES
Dove, alongside expert partners, is giving parents and caregivers tips on how to protect #TheFaceof10 LONDON, Feb. 29, 2024 /PRNewswire/ — More than ever, young girls are being exposed to adult skincare content, and it’s creating societal pressure for them to adopt unnecessary anti-a
JULIUS MEINL STRENGTHENS COMMITMENT FOR SMALLHOLDER COFFEE FARMING FAMILIES BY JOINING THE INITIATIVE FOR COFFEE&CLIMATE
VIENNA, Feb. 29, 2024 /PRNewswire/ — Premium Viennese coffee brand, Julius Meinl, has officially joined the initiative for coffee&climate (c&c), marking a significant milestone in the alliance’s ongoing efforts to address the challenges of smallholder coffee farming families pos
Generative AI adoption rates on the rise in workplaces according to new Microsoft Ireland and Trinity College Dublin report
Indigenous organisations lagging behind multinationals based in Ireland who are leveraging on average 30% more generative AI Microsoft Ireland report reveals that 49% of organisations are already using generative AI in some form at this early stage of availability.47% of organisations believe the t
NB Bancorp, Inc. Reports Full Year 2023 Financial Results
NEEDHAM, Mass., Feb. 28, 2024 /PRNewswire/ — NB Bancorp, Inc. (the “Company”) (Nasdaq Capital Market: NBBK), the holding company of Needham Bank, today announced its 2023 financial results. Concurrent with its mutual-to-stock conversion and as described in the prospectus for its in
Europe Cell and Gene Therapy Manufacturing QC Market Report 2023-2033: Increasing Demand for Cell and Gene Therapies Spurs Growth
DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Europe Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The Europe cell and gene therapy manufacturing Quality Control (QC) market is expec
Ball Corporation Announces Early Results of Cash Tender Offers for Certain Outstanding Debt Securities
WESTMINSTER, Colo., Feb. 28, 2024 /PRNewswire/ — Ball Corporation (“Ball”) (NYSE: BALL) announced today the early results of its previously announced offers to purchase for cash (i) any and all of the $1,000,000,000 aggregate principal amount of its outstanding 5.25% Senior Notes d
Genomma Lab’s ESG Rating Upgraded to A
Reflects Third Consecutive Rating Improvement in Four Years MEXICO CITY, Feb. 28, 2024 /PRNewswire/ — Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), one of the leading pharmaceutical and personal care product companies in Mexic
Talos Energy Announces Fourth Quarter and Full Year 2023 Operational and Financial Results
HOUSTON, Feb. 28, 2024 /PRNewswire/ — Talos Energy Inc. (“Talos” or the “Company”) (NYSE: TALO) today announced its operational and financial results for fiscal quarter and full year ended December 31, 2023. Talos also announced its year-end 2023 reserves estimates and
